关键字不能为空!

Enter

Homepage » News » JIC and Tamar Alliance Capital to form a strategic partnership with Australia Nature’s Care Biotech via a joint equity investment

JIC and Tamar Alliance Capital to form a strategic partnership with Australia Nature’s Care Biotech via a joint equity investment

2018-04-11

On April 11, 2018, China Jianyin Investment Limited ("JIC"), JIC Huawen Investment Limited (“JIC Huawen”), and Tamar Alliance Partners Fund I, L.P., (“Tamar Alliance Capital” and collectively, the “Buyer Consortium”) have entered into a binding agreement to acquire a majority stake in Australia Nature’s Care Biotech (“ANCB” or “Company”).  The transaction is subject to regulatory approvals and is expected to close in the second half of 2018.

ANCB is a leading vitamins, supplements, skin care, child care products manufacturer based in Sydney, Australia.  The Company is one of the largest vitamins and supplements companies in terms of market share in Australia contributed by leading brands such as Healthy Care, Nature's Care Pro Series, Royal, Vitamore, VitAustralia, Leimei and Mei Mei Organic.  Since inception in 1990, the Company has experienced continuous growth in terms of market share and brand awareness for the Healthy Care brand.  This is achieved through the founders’ commitment and dedication to high standards and quality for products manufactured in its own facility in Belrose, Australia. Over the years, the management team has continuously invested in new product development and innovation catering to changes in consumer demand and a stronger awareness for healthy lifestyle.  

With the backdrop of consumption elevation in China and its consumers’ ever increasing focus on personal health, the Buyer Consortium is very optimistic about the fast rising demand for preventive health and nutrition supplements. The boom of cross border e-commerce in China further enhances the explosive growth in need for high quality nutrition supplements from overseas countries like Australia. Upon completion of the transaction, the Buyer Consortium and founders will work together to continue to invest in maintaining a high quality production facility and launch new products suitable to consumers of all backgrounds. Furthermore, ANCB’s leading brands will benefit from such a strong partnership to further penetrate into a broader market through leveraging the Buyer Consortium’s extensive resources and market expertise in China and Southeast Asian market and management team’s greater accessibility to its products across various regions.

Deutsche Bank advised the Buyer Consortium.  Clifford Chance served as counsel to the Buyer Consortium.  UBS advised ANCB. Norton Rose Fulbright served as counsel to ANCB. 

 

*********************************************************************************

About JIC

China Jianyin Investment Ltd. (JIC) is an integrated investment group focused on equity investments with financial services, industrial manufacturing, culture & consumption and information technology as her four main investment realms. JIC was established as an SOE in September 2004 with the approval of the State Council of China. By the end of December 2017, JIC had asset under management of approximately USD 85 billion.

JIC Huawen Investment Ltd. (“JIC Huawen”), a subsidiary of JIC, was established in 2013 and headquartered in Beijing, China. As an investment platform of JIC, JIC Huawen specializes in public and private equity investments in culture and media, consumer goods and services, and healthcare industries. JIC Huawen invested both domestically and overseas.

About Tamar Alliance Capital

Established in 2017, Tamar Alliance Partners Fund I, L.P. is a private equity fund focused on consumer and healthcare opportunities with a high growth potential in Greater China and Southeast Asia.  The Fund is jointly owned by CITIC Pacific Limited and Dah Chong Hong Holdings Limited.  CITIC Pacific Limited is wholly owned by CITIC Limited, a listed company in Hong Kong and the largest conglomerate in China.  Dah Chong Hong Holdings Limited, a listed company in Hong Kong focused in motor and consumer products with a vast distribution network across Asia.

About ANCB

Established in 1990, ANCB is a leading manufacturer and wholesaler of vitamins, supplements and skin care products.

Supported by its founders' commitment to product quality, ANCB has become one of Australia's largest vitamins and supplements companies, manufacturing out of its TGA and cGMP licensed facility, with a leading portfolio of brands including Healthy Care, Nature's Care Pro Series, Royal, Vitamore, VitAustralia, Leimei and Mei Mei Organic. ANCB is based in Belrose, New South Wales.

 

Related reading

Homepage » News » JIC and Tamar Alliance Capital to form a strategic partnership with Australia Nature’s Care Biotech via a joint equity investment